Dunhill Financial’s Exact Sciences EXAS Stock Holding History

Dunhill Financial’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$224	–	1938
2025 Q4	$224	Buy	+2	New	+$161	﹤0.01%	1086
2024 Q4	–	Sell	-83	Closed	-$5.65K	–	932
2024 Q3	$5.65K	Hold	83	–	–	﹤0.01%	528
2024 Q2	$3.51K	Hold	83	–	–	﹤0.01%	463
2024 Q1	$5.73K	Hold	83	–	–	﹤0.01%	302
2023 Q4	$6.14K	Buy	+83	New	+$5.44K	0.01%	269

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Dunhill Financial's EXAS Position: Q1 2026 in Review

Dunhill Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2 shares — an estimated $224 sold.

Dunhill Financial first reported a position in EXAS in Q4 2023 and held it in 5 quarters. The position peaked at $6.14K in Q4 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Dunhill Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Dunhill Financial sold 2 Exact Sciences shares in Q1 2026, an estimated $224.
Dunhill Financial first reported a position in Exact Sciences in Q4 2023 and held it in 5 quarters.
Dunhill Financial's Exact Sciences position peaked at $6.14K in Q4 2023.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.